GSK plc Bank Overdrafts Classified As Cash Equivalents
GSK plc (GLAXF) had Bank Overdrafts Classified As Cash Equivalents of GBP 190.00 million as of 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:BankOverdraftsClassifiedAsCashEquivalents · last filed 2026-03-06
- 2025-12-31: Bank Overdrafts Classified As Cash Equivalents 190.00M GBP.
- 2024-12-31: Bank Overdrafts Classified As Cash Equivalents 467.00M GBP.
- 2023-12-31: Bank Overdrafts Classified As Cash Equivalents 78.00M GBP.
- 2022-12-31: Bank Overdrafts Classified As Cash Equivalents 298.00M GBP.
| Period end | Bank Overdrafts Classified As Cash Equivalents |
|---|---|
| 2025-12-31 | 190.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 467.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 78.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 298.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 455.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 1.03B GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 383.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 272.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 233.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 292.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 344.00M GBP 20-F/A · filed 2018-03-20 |